Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2018-10-23
Product name
8003 / 8004 / 8005
Icons in SDS
Company Information
company name
Pepin Industries limited
GHS Information
Signal word
DANGER
Section 2
2.1 Classification of the substance or mixture
SKIN CORROSION/IRRITATION - Category 1 SERIOUS EYE DAMAGE/EYE IRRITATION - Category 1 GERM CELL MUTAGENICITY - Category 1 CARCINOGENICITY - Category 1 REPRODUCTIVE TOXICITY - Category 1
Signal word
DANGER
Hazard statements
Causes severe skin burns and eye damage. Causes serious eye damage. May cause genetic defects. May cause cancer. May damage fertility or the unborn child.
Response
IF SWALLOWED : Rinse mouth. Do NOT induce vomiting. IF ON SKIN OR HAIR : Take off immediately all contaminated clothing. Rinse skin with water or shower. IF INHALED : Remove person to fresh air and keep comfortable for breathing. IF IN EYES : Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do – continue rinsing. If exposed : Call a POISON CENTER or doctor/physician. Immediately call a POISON CENTER or a doctor. Specific treatment (if necessary contact POISON CENTER). Wash contaminated clothing before reuse.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe vapours or spray. Wash hands thoroughly after handling. Wear protective gloves, protective clothing, eye protection or face protection.
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with federal, provincial and local regulation. Ingredients of 0% unknown toxicity Hazards not Otherwise N/A Classified Section 3. Ingredients CAS Ingredient Name Weight %* 7664-38-2 Phosphoric acid 85% 5-10% 25155-30-0 Benzenesulfonic acid, dodecyl-, sodium salt 1-5% 64-17-5 Ethanol 0,1-1% * Actual concentrations are withheld as a trade secret in accordance with the amendment to section 4.5 of the Hazardous Products Regulations (SOR/2018-68). Occupational exposure limits, if available, are listed in Section 8.